For other countries, any question or an interest in distributing OncoDEEP in your country please contact us at email@example.com
OncoDNA, the Cancer Theranostic Company, announced today that it has entered into a collaboration agreement with Promotora SN Zogen, a company that provides oncologic solutions in Mexico. Zogen will market and promote OncoDNA’s solutions to oncologists and their patients in Mexico. This partnership marks a new milestone in OncoDNA’s continuous expansion in Latin America.
Oncologists from Mexico will have access to the most advanced and high-tech molecular profiling program that combines liquid and solid biopsies analyses aspiring to improve the lives of patients with metastatic cancer. Patients will benefit from a personalized medicine based on today’s most comprehensive tumour profiling solution.
We’re excited to have Zogen as a partner and we are eager to join forces to help more patients. We’re impressed by Zogen’s professionalism and commitment and we are sure that having them on the ground will make a difference in metastatic cancer patients’ care and attention in Mexico”>, says Fiona Demol, International Business Development Manager at OncoDNA.
“We are thrilled to incorporate OncoDNA’s NGS Tests to our oncologic solutions. We are convinced that this new offer will help our oncologists in Mexico to take better decisions and recommend the latest treatments for patients with metastatic cancer.” Says Marcel Peguero, Managing Director at ZOGEN. .
If you are a medical doctor from Mexico and you would like to discuss about a project or collaboration opportunity, please contact OncoDNA’s local coordinator, Alexia Cornejo, at: firstname.lastname@example.org
Click on this link to download this press release: http://bit.ly/2sQ0DC7
OncoDNA, with over 60 years’ expertise in medical diagnostics, was founded by a team of experts with many years of experience in DNA sequencing and diagnostic analyses in oncology.